PureHealth finalises €800 million acquisition of Hellenic Healthcare Group to strengthen global network

The integration of HHG’s 11 hospitals and 23 diagnostic centres will allow PureHealth to deliver healthcare services to more than 1.4 million patients annually.

(L-R) Alex Fotakidis, Partner and Head of Greece at CVC; H.E. Dr Ali Obaid Ali Alyabhouni Aldhaheri, Ambassador of the United Arab Emirates to the Hellenic Republic; H.E. Kyriakos Pierrakakis, Minister of National Economy and Finance of Greece; Shaista Asif, Group Chief Executive Officer of PureHealth; H.E. Kyriakos Pierrakakis, Minister of National Economy and Finance of Greece; Dimitris Spyridis, CEO of HHG | Image source: purehealth.ae
WT default author logo
Women's Tabloid News Desk

PureHealth Holding PJSC (PureHealth), the Middle East’s largest healthcare group, has completed its €800 million acquisition of a 60% stake in Hellenic Healthcare Group (HHG), the leading private healthcare provider in Greece and Cyprus. The deal values HHG at €1.3 billion and marks a major step in PureHealth’s long-term plan to develop a globally connected, innovation-focused healthcare platform from its base in Abu Dhabi.

The integration of HHG’s 11 hospitals and 23 diagnostic centres will allow PureHealth to deliver healthcare services to more than 1.4 million patients annually. With a workforce of over 6,900 healthcare professionals, HHG will now become part of PureHealth’s growing international network, further strengthening Abu Dhabi’s position as a global centre for healthcare excellence and investment.

A signing ceremony marking the completion of the transaction took place in Greece and was attended by senior officials including H.E. Kyriakos Pierrakakis, Minister of National Economy and Finance of Greece; H.E. Adonis Georgiadis, Minister of Health of the Hellenic Republic; H.E. Dr Ali Obaid Ali Alyabhouni Aldhaheri, Ambassador of the United Arab Emirates to the Hellenic Republic; and senior executives from PureHealth, CVC Capital Partners and HHG.

H.E. Kamal Al Maazmi, Chairman of PureHealth, said: “Finalising this transaction is an important milestone in our journey to create a globally connected healthcare platform. PureHealth has demonstrated the ability to source, execute and secure regulatory approvals in mature markets, reflecting its strengths and international credibility. With HHG, we are now expanding into new geographies, facilitating knowledge exchange, and fostering innovation that will enhance patient outcomes across our network. Importantly, this acquisition has been completed using PureHealth’s strong balance sheet, and we expect to recognise the financial upside from October 1, 2025.”

Shaista Asif, Group Chief Executive Officer of PureHealth, added: “Welcoming HHG into the Group accelerates our vision of delivering advanced, patient-centred healthcare across borders. This transaction strengthens medical expertise, broadens access to quality care, and diversifies revenues across mature geographies and currencies. It underscores our long-term commitment to value creation for patients, communities, and our shareholders. Central to PureHealth’s ambition is the power of AI and our expanding digital footprint, which enable us to transform healthcare delivery on a global scale. Being able to rely on best-in-class talent, from doctors and scientists to cutting-edge technology, across our global network gives us the edge as we build synergies and innovate across our platform.”

Global Expansion Through Strategic Acquisitions

The HHG acquisition is the latest in a series of international deals by PureHealth as part of its expansion strategy. In 2024, the company acquired Circle Health Group, the UK’s largest independent hospital operator, for USD 1.2 billion. This followed a USD 500 million investment in Ardent Health Services in the US in 2022, which led to Ardent’s IPO on the New York Stock Exchange in 2024. These moves reflect PureHealth’s disciplined approach to building a diversified global portfolio across multiple regions and currencies.

Alex Fotakidis, Partner and Head of Greece at CVC, said: “We are proud to have supported HHG’s growth into Greece and Cyprus’s leading private healthcare provider. This partnership with PureHealth is a strong endorsement of HHG’s quality, scale, and future potential. By combining PureHealth’s international expertise with HHG’s established presence in Southern Europe, we are confident this transaction will deliver lasting value for patients, employees, and will accelerate the growth of HHG.”

Dimitris Spyridis, CEO of HHG, added: “Joining forces with PureHealth marks an important milestone for HHG. Together, we will accelerate innovation, enhance patient care, and strengthen our role as the leading healthcare provider in Greece and Cyprus. PureHealth has a large emphasis on technology, AI and healthcare of the future. Therefore we will be looking to integrate best practices not only in clinical practices, but also across the technology ecosystem.”

Following the completion of the acquisition, CVC Capital Partners and HHG’s management team will retain a 40% stake in the company, ensuring continuity and supporting the next phase of its growth.

PureHealth’s latest deal marks a significant milestone in its transformation into a major global healthcare player, expanding its international reach while creating new opportunities for collaboration, innovation, and enhanced patient care across its network.

Share:

Related Insights